Assessing nutritional status in gastric cancer patients using bioelectrical impedance analysis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the nutritional status and body composition of gastric cancer patients undergoing multimodal treatment through bioelectrical impedance analysis. It will include 125 patients with locally advanced gastric adenocarcinoma, who will undergo four consecutive nutritional assessments during their treatment. The goal is to determine if this method can serve as a validated tool to support clinical decisions regarding patient care. By understanding the relationship between nutritional status and tumor regression, the study seeks to address the high rates of malnutrition in this patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥ 18 years
2. Histologically confirmed gastric adenocarcinoma (or undifferentiated carcinoma)
3. Stage II - III disease (cT2 cN+ and cT3-T4 cN+/-) based on the 8th edition of TNM classification
4. Qualification for multimodal treatment by the decision of the multidisciplinary tumor board

Exclusion Criteria:

1. Early gastric cancer (cT1N0-3M0) scheduled for endoscopic treatment by multidisciplinary team
2. Gastric stump carcinoma
3. Distant metastasis
4. Upfront surgery
5. Other malignancies
6. Contraindications to bioelectrical impedance analysis (e.g., implanted cardiac devices, metal implants or pregnancy)

Where it's running

• Medical University of Lublin
  Lublin, Poland Recruiting

Study contacts

• Principal investigator: Zuzanna Pelc, PhD — Medical University of Lublin
• Study coordinator: Zuzanna Pelc, PhD
• Email: zuzannapelc@umlub.pl
• Phone: +48 81 531 81 26

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Olanzapine added to chemotherapy for gastric cancer to help keep weight and appetite up

  This study tests whether adding low-dose olanzapine to standard neoadjuvant chemotherapy helps patients with gastric cancer maintain weight and appetite during treatment.

  Recruiting Phase 2 University of Illinois Chicago · Chicago, Illinois · NCT07581405

• BHB810 in advanced gastric and GEJ cancer (early-phase)

  This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.

  Recruiting at 2 sites Phase 1/2 BigHat Biosciences, Inc. · Duarte, California and 2 other locations · NCT07529808

• High-protein, plant-dominant diet for people with liver cirrhosis

  This 6-month test compares a high-protein, mostly plant-based diet to a usual low-fat animal-protein diet in adults with decompensated cirrhosis who are awaiting kidney transplant to see which better preserves nutrition and muscle.

  Recruiting at 2 sites Agricultural University of Athens · Athens, Attica and 1 other locations · NCT07028580

• Direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal and gastrointestinal tumors

  This trial will try a single direct injection of a modified vaccinia virus (vvDD-hIL2) into abdominal tumors to see if it is safe for adults with advanced metastatic gastrointestinal or peritoneal cancers who have not responded to standard treatments.

  Recruiting Phase 1 Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania · NCT07001592

• Evaluating Nano-Crystalline Megestrol Acetate for Cachexia in Advanced Digestive Tumors

  This study is testing if a new form of Megestrol Acetate can help adults with advanced digestive tumors gain weight and feel better while they are on cancer treatment.

  Recruiting at 2 sites Changchun GeneScience Pharmaceutical Co., Ltd. · Shenyang, Liaoning and 1 other locations · NCT06940102

• Impact of protein intake on muscle mass and quality of life during and after radiotherapy

  This study looks at how eating enough protein can help cancer patients keep their muscle mass and improve their quality of life during and after radiotherapy.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT06480266

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.